Johns DG - Search Results

1

Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates.

Johns DG. Johns DG. J Clin Invest. 1967 Sep;46(9):1492-505. doi: 10.1172/JCI105641. J Clin Invest. 1967. PMID: 4226961 Free PMC article.

2

Studies on the mode of oxidation of pyrazolo(3,4-d)pyrimidine by aldehyde oxidase and xanthine oxidase.

Johns DG, Spector T, Robins RK. Johns DG, et al. Biochem Pharmacol. 1969 Oct;18(10):2371-83. doi: 10.1016/0006-2952(69)90352-9. Biochem Pharmacol. 1969. PMID: 5403975 No abstract available.

3

Purification and properties of cytidine deaminase from normal and leukemic granulocytes.

Chabner BA, Johns DG, Coleman CN, Drake JC, Evans WH. Chabner BA, et al. Among authors: johns dg. J Clin Invest. 1974 Mar;53(3):922-31. doi: 10.1172/JCI107633. J Clin Invest. 1974. PMID: 4521417 Free PMC article.

4

The metabolism of tritiated folic acid in man.

JOHNS DG, SPERTI S, BURGEN AS. JOHNS DG, et al. J Clin Invest. 1961 Sep;40(9):1684-95. doi: 10.1172/JCI104391. J Clin Invest. 1961. PMID: 13790219 Free PMC article. No abstract available.

5

Quinazoline antifolates as inhibitors of dihydrofolate reductase from human leukemia cells.

Johns DG, Capizzi RL, Nahas A, Cashmore AR, Bertino JR. Johns DG, et al. Biochem Pharmacol. 1970 Apr;19(4):1528-33. doi: 10.1016/0006-2952(70)90076-6. Biochem Pharmacol. 1970. PMID: 5284463 No abstract available.

6

The relative toxicites of methotrexate and aminopterin.

Johns DG, Iannotti AT, Sartorelli AC, Bertino JR. Johns DG, et al. Biochem Pharmacol. 1966 May;15(5):555-61. doi: 10.1016/0006-2952(66)90022-0. Biochem Pharmacol. 1966. PMID: 5961434 No abstract available.

7

Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid.

Valerino DM, Johns DG, Zaharko DS, Oliverio VT. Valerino DM, et al. Among authors: johns dg. Biochem Pharmacol. 1972 Mar 15;21(6):821-31. doi: 10.1016/0006-2952(72)90125-6. Biochem Pharmacol. 1972. PMID: 5014749 No abstract available.

8

Oxidation of 4-hydroxypyrazolo (3,4-d) pyrimidine by xanthine oxidase, the route of electron transfer from substrate to acceptor dyes.

Spector T, Johns DG. Spector T, et al. Among authors: johns dg. Biochem Biophys Res Commun. 1968 Sep 30;32(6):1039-44. doi: 10.1016/0006-291x(68)90134-4. Biochem Biophys Res Commun. 1968. PMID: 5750222 No abstract available.

9

Anomalous differential effects of 4-hydroxypyrazolo (3,4-d)-pyrimidine on electron transfer from xanthine oxidase to molecular oxygen and to acceptor dyes.

Johns DG. Johns DG. Biochem Biophys Res Commun. 1968 Apr 19;31(2):197-202. doi: 10.1016/0006-291x(68)90730-4. Biochem Biophys Res Commun. 1968. PMID: 5656067 No abstract available.

10

4-Hydroxypyrazolo (3,4-d) pyrimidine as a substrate for xanthine oxidase: loss of conventional substrate activity with catalytic cycling of the enzyme.

Spector T, Johns DG. Spector T, et al. Among authors: johns dg. Biochem Biophys Res Commun. 1970 Feb 20;38(4):583-9. doi: 10.1016/0006-291x(70)90621-2. Biochem Biophys Res Commun. 1970. PMID: 5462699 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results